NCT00051038View on ClinicalTrials.gov

Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2002

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Hepatitis B
Interventions
DRUG

Entecavir

Trial Locations (5)

Unknown

Local Institution, New Haven

Local Institution, Altamonte Springs

Local Institution, Lousiville

Local Institution, Charlotte

Local Institution, Pittsburgh

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY